To test this hypothesis, control- and SPARC-transfected glioma cells were assessed in vivo and in vitro for SPARC-induced changes in matrix production, vascularity, VEGF-VEGFR expression and SPARC-VEGF interaction. This evidence concerns the gene VEGFA and central nervous system cancer.